BASEL, SWITZERLAND – The recent EU Variations Regulation that took effect in January is expected to simplify and future-proof the process for implementing manufacturing changes for medicinal products, ...
NEW YORK& TOKYO---- Pfizer Inc. and Astellas Pharma Inc. today announced that on January 26 the European Medicines Agency validated for review a Type II variation application for PADCEV ® with ...
The European Commission has finalized plans to improve lifecycle management of medicines through changes to the regulations on marketing authorization variations. European Union lawmakers last made ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results